跳至主要内容
临床试验/IRCT20200331046900N1
IRCT20200331046900N1已完成3 期

Evaluation the Effect of Oral Aloe Vera Administration on Fasting Plasma Glucose, Lipid Profile, Body Composition Components, Anthropometric Indices, and Blood Pressure Values in Patients with Diabetes Type 2

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 69 years(—)
性别
All

入选标准

  • The desire to participate in the study
  • Age range 18 to 69 years
  • Diagnosis of type 2 diabetes by a specialist
  • The minimum duration of type 2 diabetes is 6 months
  • Weight constant over the past 6 months ( Self-report )
  • The type and dose of medications taken have been stable over the past 6 months

排除标准

  • Allergy to aloe vera or products containing it
  • Pregnancy and lactation
  • Use of any dietary supplement in the last 6 months
  • Smoking and addiction
  • Acute heart disease, stroke, liver, kidney, gastrointestinal, thyroid and parathyroid disease, rheumatoid and infectious arthritis

研究者

相似试验